Back to search
FDAFDA · Food and drugs·Recall number Z-2396-2024

Infusomat SPACE PUMP IV SET 15D, 90 IN. Used with an electrically-powered infusion pump for intravenous (IV) administration of medication Model/ Catalog Number 480263

Published July 24, 2024 · Recall initiated: June 17, 2024

Summary

FDA records medical device Class II recall Z-2396-2024, published July 24, 2024 and initiated June 17, 2024. Recalling firm: B. Braun Medical, Inc.; Status: Ongoing; Reported quantity: 13464 units; Lot: UDI-DI 04046955693931; All Lots Distributed After 25SEP2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for the backcheck valve to malfunction, resulting in backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime, resulting in patient injuries of adverse drug reaction and/or product malfunction with loss of medication/blood.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B. Braun Medical, Inc.
Distributor
Worldwide distribution - US Nationwide and the country of Canada.
Lot
UDI-DI 04046955693931; All Lots Distributed After 25SEP2023.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Infusomat SPACE PUMP IV SET 15D, 90 IN. Used with an electrically-powered infusion pump for intravenous (IV) administration of medication Model/ Catalog Number 480263 recalled?

Yes. FDA published recall Z-2396-2024 on July 24, 2024. Reported hazard: Potential for the backcheck valve to malfunction, resulting in backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime, resulting in patient injuries of adverse drug reaction and/or product malfunction with loss of medication/blood.

What should I do if I have this product?

Voluntary: Firm initiated · Letter